phosphorylethanolamine has been researched along with Hypertension in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Licata, AA | 1 |
| Radfar, N | 1 |
| Bartter, FC | 1 |
| Bou, E | 1 |
1 other study available for phosphorylethanolamine and Hypertension
| Article | Year |
|---|---|
The urinary excretion of phosphoethanolamine in diseases other than hypophosphatasia.
Topics: Adolescent; Adult; Age Factors; Bone Diseases; Child; Circadian Rhythm; Dietary Proteins; Endocrine | 1978 |